Price T Rowe Associates Inc Health Sciences Acquisitions Corp 2 Transaction History

Price T Rowe Associates Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$9.8 - $10.02 $25,842 - $26,422	-2,637 Reduced 0.36%	724,565 $7.18 Million
Q2 2022 Aug 15, 2022	SELL	$9.9 - $9.98 $662,072 - $667,422	-66,876 Reduced 8.42%	727,202 $7.24 Million
Q1 2022 May 16, 2022	SELL	$9.82 - $9.92 $45,221 - $45,681	-4,605 Reduced 0.58%	794,078 $7.87 Million
Q4 2021 Feb 14, 2022	SELL	$9.81 - $10.08 $89,094 - $91,546	-9,082 Reduced 1.12%	798,683 $7.99 Million
Q3 2021 Nov 15, 2021	SELL	$9.74 - $10.05 $23,113 - $23,848	-2,373 Reduced 0.29%	807,765 $7.99 Million
Q2 2021 Aug 16, 2021	SELL	$9.97 - $11.16 $397,424 - $444,859	-39,862 Reduced 4.69%	810,138 $8.26 Million
Q4 2020 Feb 16, 2021	BUY	$10.61 - $13.0 $9.02 Million - $11.1 Million	850,000 New	850,000 $10.9 Million

Ticker HSAQ
Exchange NASDAQ
Sector Financial Services
Industry Shell Companies
Shares Outstandng 11,212,100
Description
Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Science...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.